NLS Pharmaceutics AG
NASDAQ:NLSP
NLS Pharmaceutics AG
NASDAQ:NLSP
Price:
0.141 USD
-15.16%
Updated:
Jun 3, 2024
NLS Pharmaceutics AG
Selling, General & Administrative
|
NLS Pharmaceutics AG
Selling, General & Administrative Peer Comparison
Comparables:
NOVN
ROG
S
SDZ
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Selling, General & Administrative
-$5.9m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Novartis AG
SIX:NOVN
|
Selling, General & Administrative
-$15.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
0%
|
|
|
Roche Holding AG
SIX:ROG
|
Selling, General & Administrative
-CHf13.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Selling, General & Administrative
-$2.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is NLS Pharmaceutics AG's Selling, General & Administrative?
Selling, General & Administrative
-5.9m
USD
-5.9m
USD
Based on the financial report for Dec 31, 2023, NLS Pharmaceutics AG's Selling, General & Administrative amounts to -5.9m USD.
What is NLS Pharmaceutics AG's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-24%
-24%
Over the last year, the Selling, General & Administrative growth was 9%. The average annual Selling, General & Administrative growth rates for NLS Pharmaceutics AG have been -39% over the past three years , -24% over the past five years .
You don't have any saved screeners yet
